Efficacy of glutathione inhibitors for the treatment of ARID1A-deficient diffuse-type gastric cancers

被引：0
|
作者：
Sasaki, Mariko [1 ]
Chiwaki, Fumiko [2 ]
Kohno, Takashi [3 ]
Sasaki, Hiroki [2 ]
Ogiwara, Hideaki [1 ]
机构：
[1] Nat Canc Res Ctr, Canc Therap, Tokyo, Japan
[2] Nat Canc Res Ctr, Dept Transl Res, Tokyo, Japan
[3] Nat Canc Res Ctr, Genome Biol, Tokyo, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P16-2-3
引用
收藏
页码：1759 / 1759
页数：1
相关论文
共 50 条
  • [1] Efficacy of glutathione inhibitors for the treatment of ARID1A-deficient diffuse-type gastric cancers
    Sasaki, Mariko
    Chiwaki, Fumiko
    Kuroda, Takafumi
    Komatsu, Masayuki
    Matsusaki, Keisuke
    Kohno, Takashi
    Sasaki, Hiroki
    Ogiwara, Hideaki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 522 (02) : 342 - 347
  • [2] Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers
    Ogiwara, Hideaki
    Takahashi, Kazuaki
    Sasaki, Mariko
    Kuroda, Takafumi
    Yoshida, Hiroshi
    Watanabe, Reiko
    Maruyama, Ami
    Makinoshima, Hideki
    Chiwaki, Fumiko
    Sasaki, Hiroki
    Kato, Tomoyasu
    Okamoto, Aikou
    Kohno, Takashi
    CANCER CELL, 2019, 35 (02) : 177 - +
  • [3] Glutathione Metabolism: An Achilles' Heel of ARID1A-Deficient Tumors
    Gorrini, Chiara
    Mak, Tak W.
    CANCER CELL, 2019, 35 (02) : 161 - 163
  • [4] Genomic profile analysis of diffuse-type gastric cancers
    Yeon-Su Lee
    Yun Sung Cho
    Geon Kook Lee
    Sunghoon Lee
    Young-Woo Kim
    Sungwoong Jho
    Hak-Min Kim
    Seung-Hyun Hong
    Jung-Ah Hwang
    Sook-young Kim
    Dongwan Hong
    Il Ju Choi
    Byung Chul Kim
    Byoung-Chul Kim
    Chul Hong Kim
    Hansol Choi
    Youngju Kim
    Kyung Wook Kim
    Gu Kong
    Hyung Lae Kim
    Jong Bhak
    Seung Hoon Lee
    Jin Soo Lee
    Genome Biology, 15
  • [5] Genomic profile analysis of diffuse-type gastric cancers
    Lee, Yeon-Su
    Cho, Yun Sung
    Lee, Geon Kook
    Lee, Sunghoon
    Kim, Young-Woo
    Jho, Sungwoong
    Kim, Hak-Min
    Hong, Seung-Hyun
    Hwang, Jung-Ah
    Kim, Sook-young
    Hong, Dongwan
    Choi, Il Ju
    Kim, Byung Chul
    Kim, Byoung-Chul
    Kim, Chul Hong
    Choi, Hansol
    Kim, Youngju
    Kim, Kyung Wook
    Kong, Gu
    Kim, Hyung Lae
    Bhak, Jong
    Lee, Seung Hoon
    Lee, Jin Soo
    GENOME BIOLOGY, 2014, 15 (04):
  • [6] AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells
    Lee, D. -E.
    VIRCHOWS ARCHIV, 2017, 471 : S194 - S194
  • [7] AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells
    Lee, Dakeun
    Yu, Eun Ji
    Ham, In-Hye
    Hur, Hoon
    Kim, You-Sun
    ONCOTARGETS AND THERAPY, 2017, 10 : 4153 - 4159
  • [8] Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective
    Lebedev, Timofey
    Kousar, Rubina
    Patrick, Bbumba
    Usama, Muhammad
    Lee, Meng-Kuei
    Tan, Ming
    Li, Xing-Guo
    CELLS, 2023, 12 (06)
  • [9] Selective sensitivity of EZH2 inhibitors based on synthetic lethality in ARID1A-deficient gastric cancer
    Yamada, Leo
    Saito, Motonobu
    Min, Aung Kyi Thar
    Saito, Katsuharu
    Ashizawa, Mai
    Kase, Koji
    Nakajima, Shotaro
    Onozawa, Hisashi
    Okayama, Hirokazu
    Endo, Hisahito
    Fujita, Shotaro
    Sakamoto, Wataru
    Saze, Zenichiro
    Momma, Tomoyuki
    Mimura, Kosaku
    Ohki, Shinji
    Kono, Koji
    GASTRIC CANCER, 2021, 24 (01) : 60 - 71
  • [10] Nucleotide variants within the IQGAPI gene in diffuse-type gastric cancers
    Morris, LE
    Bloom, GS
    Frierson, HF
    Powell, SM
    GENES CHROMOSOMES & CANCER, 2005, 42 (03): : 280 - 286
12345